Oncology News

Liver cancer mortality rates are expected to increase in the coming decades and disparities in occurrence by race, ethnicity, sex and state location in the U.S. continue to persist, according to a recently published study.

Despite current clinical practice guidelines recommending that clinicians use life expectancy to inform cancer screening, many older adults do not consider life expectancy to be an important factor in screening and prefer not to discuss it, according to findings published in JAMA Internal Medicine.

More than 2 billion children and adults globally were affected by excess weight in 2015, and the percentage of people dying from health conditions stemming from being overweight or obese is rising, according to findings published in The New England Journal of Medicine.

Surefire Medical released results of a retrospective study of bridge-to-transplant patients with hepatocellular carcinoma treated with transarterial chemoembolization, or DEB-TACE, that showed a higher complete response rate using the Surefire Infusion System compared with standard endhole microcatheter, according to a press release.

CHICAGO — Results of a phase 3 trial showed that Lenvima was non-inferior to Nexavar in median overall survival for patients with unresectable hepatocellular carcinoma, according to a presentation at the ASCO Annual Meeting.

Exposure to air pollution with particulate matter over 2.5 m in diameter, or PM2.5, after diagnosis of hepatocellular carcinoma had adverse effects in patients and may shorten overall survival, according to a retrospective study.

New data revealed an association between postmenopausal estrogen use and a reduced risk for hepatocellular carcinoma and increased overall survival time in women with HCC.

Viral eradication with direct-acting antivirals does not appear associated with an increased risk for liver transplant waitlist drop-out due to hepatocellular carcinoma progression in patients with hepatitis C, according to a recently published study.

Among the presentations at this year’s Digestive Disease Week, physician experts and clinical professionals discussed new data on liver disease diagnosis and treatment, including topics such as gut microbiota, liver transplantation, fatty liver disease and viral hepatitis, as well as advances in the world of telemedicine and unique approaches in patient management.

The FDA granted priority review to nivolumab for the treatment of hepatocellular carcinoma, according to the drug’s manufacturer.